Considerable research has suggested treatment targeting vascular endothelial growth factor (VEGF) among such angiogenic growth factors to extend the prognosis of patients with unresectable colorectal cancer [8], and this treatment has been listed in NCCN's guidelines as a molecular therapy for colorectal cancer [9]. This evidence concerns the gene VEGFA and colorectal cancer.